REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,313,824 | -81.7% | 812,016 | -59.6% | 0.01% | -82.7% |
| Q2 2023 | $50,915,343 | -31.0% | 2,011,669 | -12.2% | 0.05% | -34.2% |
| Q1 2023 | $73,822,453 | +198.7% | 2,291,911 | +71.2% | 0.08% | +192.6% |
| Q4 2022 | $24,716,463 | -37.7% | 1,338,920 | -8.9% | 0.03% | -42.6% |
| Q3 2022 | $39,678,000 | +251.1% | 1,469,573 | +79.7% | 0.05% | +261.5% |
| Q2 2022 | $11,302,000 | -31.5% | 817,740 | -3.4% | 0.01% | -13.3% |
| Q1 2022 | $16,502,000 | +93.0% | 846,268 | +61.5% | 0.02% | +114.3% |
| Q4 2021 | $8,550,000 | +3226.8% | 523,918 | +5570.1% | 0.01% | – |
| Q3 2021 | $257,000 | -82.0% | 9,240 | -80.8% | 0.00% | -100.0% |
| Q2 2021 | $1,425,000 | +463.2% | 48,087 | +438.3% | 0.00% | – |
| Q4 2020 | $253,000 | -68.1% | 8,933 | -71.7% | 0.00% | -100.0% |
| Q3 2020 | $794,000 | +193.0% | 31,584 | +184.3% | 0.00% | – |
| Q2 2020 | $271,000 | +48.9% | 11,111 | -9.7% | 0.00% | – |
| Q1 2020 | $182,000 | -35.2% | 12,300 | -43.3% | 0.00% | – |
| Q2 2019 | $281,000 | -40.1% | 21,686 | -27.1% | 0.00% | -100.0% |
| Q1 2019 | $469,000 | -76.8% | 29,729 | -70.4% | 0.00% | -66.7% |
| Q4 2018 | $2,023,000 | +24.9% | 100,490 | +54.1% | 0.00% | +50.0% |
| Q3 2018 | $1,620,000 | -24.3% | 65,202 | -16.4% | 0.00% | -33.3% |
| Q2 2018 | $2,141,000 | +648.6% | 77,994 | +739.7% | 0.00% | – |
| Q1 2018 | $286,000 | -81.9% | 9,288 | -79.0% | 0.00% | -100.0% |
| Q4 2017 | $1,579,000 | +611.3% | 44,172 | +312.2% | 0.00% | – |
| Q4 2016 | $222,000 | -76.7% | 10,717 | -80.4% | 0.00% | -100.0% |
| Q1 2016 | $954,000 | -82.5% | 54,621 | -65.8% | 0.00% | -75.0% |
| Q4 2015 | $5,464,000 | +622.8% | 159,939 | +529.7% | 0.01% | +700.0% |
| Q3 2015 | $756,000 | -43.4% | 25,400 | -39.2% | 0.00% | -50.0% |
| Q2 2015 | $1,336,000 | – | 41,772 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |